脂肪酸代谢与卵巢癌

doi:10.11904/j.issn.1002-3070.2023.05.007

Abstract

Abstract: Ovarian cancer is a common malignant tumor in the female reproductive system, and its pathogenesis and regulatory mechanisms are extremely complex and still unclear. Fatty acid metabolism mainly involves the processes of fatty acid uptake, synthesis, and oxidation. Previous studies have shown that fatty acid metabolism plays a unique role in the occurrence and development of ovarian cancer. Therefore, this article reviews existing literature and delves into the correlation between fatty acid metabolism and ovarian cancer, aiming to provide new perspectives and reflections on the mechanism of fatty acid metabolism and targeted treatment of ovarian cancer.

Key words: Ovarian cancer, Fatty acid metabolism, Enzymes, Targeted therapy

CLC Number:

R737.31

FAN Tingting, DING Danni, ZHAO Zixue, YU Yang, HAN Fengjuan. Fatty acid metabolism and ovarian cancer[J]. Journal of Practical Oncology, 2023, 37(5): 429-433.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2023.05.007

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2023/V37/I5/429

References

1 Kong BH,Liu JH,Huang H,et al.Clinical application guidelines for PARP inhibitors in ovarian cancer(2022 Edition)[J].Progress in Obstetrics and Gynecology,2022,31(8):561-572.
2 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021 May;71(3):209-249.
3 Huang X,Feng B,Liu M,et al.Preclinical detection of lysophosphatidic acid:A new window for ovarian cancer diagnostics[J].Talanta,2022,247:123561.
4 Koundouros N,Poulogiannis G.Reprogramming of fatty acid metabolism in cancer[J].Br J Cancer,2020,122(1):4-22.
5 Chen YJ,Liao WX,Huang SZ,et al.Prognostic and immunological role of CD36:A pan-cancer analysis[J].J Cancer,2021,12(16):4762-4773.
6 Pascual G,Avgustinova A,Mejetta S,et al.Targeting metastasis-initiating cells through the fatty acid receptor CD36[J].Nature,2017,541(7635):41-45.
7 Gharpure KM,Pradeep S,Sans M,et al.FABP4 as a key determinant of metastatic potential of ovarian cancer[J].Nat Commun,2018,9:2923.
8 Granchi C.ATP citrate lyase(ACLY)inhibitors:An anti-cancer strategy at the crossroads of glucose and lipid metabolism[J].Eur J Med Chem,2018,157:1276-1291.
9 Wang Y,Wang Y,Shen L,et al.Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer[J].Oncol Rep,2012,27(4):1156-1162.
10 Bauerschlag DO,Maass N,Leonhardt P,et al.Fatty acid synthase overexpression:target for therapy and reversal of chemoresistance in ovarian cancer[J].J Transl Med,2015,13:146.
11 Jiang L,Fang X,Wang H,et al.Ovarian cancer-Intrinsic fatty acid synthase prevents anti-tumor immunity by disrupting tumor-infiltrating dendritic cells[J].Front Immunol,2018,9:2927.
12 Ji Z,Shen Y,Feng X,et al.Deregulation of lipid metabolism:The critical factors in ovarian cancer[J].Front Oncol,2020,10:593017.
13 Xuan Y,Wang H,Yung MM,et al.SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells[J].Theranostics,2022,12(7):3534-3552.
14 Tesfay L,Paul BT,Konstorum A,et al.Steroyl-CoA Desaturase 1(SCD1)protects ovarian cancer cells from ferroptotic cell death[J].Cancer Res,2019,79(20):5355-5366.
15 Luis G,Godfroid A,Nishiumi S,et al.Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1(SCD1)in cancer cells and Fatty Acid Biding Protein-4(FABP4)in tumor microenvironment promote tumor recurrence[J].Redox Biol,2021,43:102006.
16 Sawyer BT,Qamar L,Yamamoto TM,et al.Targeting fatty acid oxidation to promote anoikis and inhibit ovarian cancer progression[J].Mol Cancer Res,2020,18(7):1088-1098.
17 Yang H,Zhao H,Ren Z,et al.Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC[J].Acta Biochim Biophys Sin,2022,54(2):220-231.
18 Icard P,Wu Z,Fournel L,et al.ATP citrate lyase:A central metabolic enzyme in cancer[J].Cancer Lett,2020,471:125-134.
19 Falchook G,Infante J,Arkenau HT,et al.First-in-human study of the safety,pharmacokinetics,and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors[J].EClinicalMedicine,2021,34:100797.
20 Grunt TW,Slany A,Semkova M,et al.Membrane disruption,but not metabolic rewiring,is the key mechanism of anticancer-action of FASN-inhibitors:a multi-omics analysis in ovarian cancer[J].Sci Rep,2020,10(1):14877.
21 Tesfay L,Paul BT,Konstorum A,et al.Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death[J].Cancer Res,2019,79(20):5355-5366.
22 Liu Y,Liu X,Wang H,et al.Agrimonolide inhibits cancer progression and induces ferroptosis and apoptosis by targeting SCD1 in ovarian cancer cells[J].Phytomedicine,2022,101:154102.
23 Jin HR,Wang J,Wang ZJ,et al.Lipid metabolic reprogramming in tumor microenvironment:from mechanisms to therapeutics[J].J Hematol Oncol,2023,16:103.
24 Reyes-Castellanos G,Abdel Hadi N,Gallardo-Arriaga S,et al.Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo[J].iScience,2023,26(6):106899.

[1]	GAO Yan, YAO Mengcheng, LI Zhefeng, HAN Xiaoyang, YUE Wentao. Single cell sequencing data reveal the diagnostic and predictive value of DMKN in ovarian cancer [J]. Journal of Practical Oncology, 2023, 37(6): 478-484.
[2]	LUN Lixin, ZHONG Zhenbin, ZHAO Xinyu, WU Chou, HAO Chuncheng. Research progress of anti-EGFR therapy in head and neck squamous cell carcinoma [J]. Journal of Practical Oncology, 2023, 37(3): 276-280.
[3]	WANG Jiabei, ZHANG Yunguang, LIU Lianxin. Clinical efficacy and safety analysis of immunotherapy combined with molecularly targeted drugs in the treatment of advanced hepatocellular carcinoma:A single-arm retrospective study [J]. Journal of Practical Oncology, 2022, 36(6): 489-494.
[4]	ZHAO Yaru, WU Yun. Research status of common biomarkers and corresponding targeted therapy for gastric cancer [J]. Journal of Practical Oncology, 2022, 36(5): 483-488.
[5]	SUN Fusheng, XU Ye, ZHANG Yongjian, LOU Ge. Research progress and new treatment strategies of ovarian cancer organoids [J]. Journal of Practical Oncology, 2022, 36(4): 346-350.
[6]	ZHENG Yanli, HE Jianxia. Research progress of DNA methylation in diffuse large B-cell lymphoma [J]. Journal of Practical Oncology, 2022, 36(3): 259-262.
[7]	CHEN Su, SUI Hong. Research progress of anti-HER2 therapy in metastatic colorectal cancer [J]. Journal of Practical Oncology, 2022, 36(3): 288-292.
[8]	YIN Yi, OU Chaoyang, HE Aiqin. Expression of GAB2 in ovarian cancer and its correlation with prognosis [J]. Journal of Practical Oncology, 2022, 36(2): 150-155.
[9]	WU Fangfang, ZHENG Tongsen. Research status and prospect of adjuvant therapy for biliary tract malignant tumors [J]. Journal of Practical Oncology, 2022, 36(2): 156-161.
[10]	HOU Jianxun, WANG Hongbin. Research progress on the influence of exosomes in the integration of breast cancer diagnosis and treatment [J]. Journal of Practical Oncology, 2022, 36(2): 178-182.
[11]	DONG Lina, LIANG Tian, ZHANG Xian, ZHANG Guangmei. Research progress on tropism of ovarian cancer to fat-rich omentum organs [J]. Journal of Practical Oncology, 2022, 36(1): 54-58.
[12]	MA Buhuan¹, LIU Caixia². Research progress of Jagged1 promoting the occurrence,development and distant metastasis of breast cancer [J]. Journal of Practical Oncology, 2021, 35(5): 452-457.
[13]	ZHANG Wenwen,JIANG Liangliang,WANG Jing. Application prospect of CAR-T therapy in ovarian cancer [J]. Journal of Practical Oncology, 2021, 35(1): 59-63.
[14]	YANG Siqi,SONG Qibin,LI Qingqing,YAO Yi. Research progress of targeted inhibition of FGFRs signal in the treatment of malignant tumors [J]. Journal of Practical Oncology, 2021, 35(1): 73-77.
[15]	SONG Jiayu, FENG Yue, WANG Zhao, ZHANG Yunyan. The latest research progress of the correlation between exosomes and gynecological malignant tumor [J]. Journal of Practical Oncology, 2020, 34(6): 571-575.

Fatty acid metabolism and ovarian cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments